|
1.
|
L RazzoukV MathewRJ LennonAspirin use is
associated with an improved long-term survival in an unselected
population presenting with unstable anginaClin
Cardiol33553558201010.1002/clc.2076920842739
|
|
2.
|
RA KlonerNatural and unnatural triggers of
myocardial infarctionProg Cardiovasc
Dis48285300200610.1016/j.pcad.2005.07.00116517249
|
|
3.
|
JL AndersonCD AdamsEM AntmanACC/AHA 2007
Guidelines for the Management of Patients with Unstable Angina/
Non-ST-Elevation Myocardial Infarction: a report of the American
College of Cardiology/American Heart Association Task Force on
Practice Guidelines (Writing Committee to Revise the 2002
Guidelines for the Management of Patients with Unstable Angina/
Non-ST-Elevation Myocardial Infarction): developed in collaboration
with the American College of Emergency Physicians, the Society for
Cardiovascular Angiography and Interventions, and the Society of
Thoracic Surgeons: endorsed by the American Association of
Cardiovascular and Pulmonary Rehabilitation and the Society for
Academic Emergency MedicineCirculation116e148e3042007
|
|
4.
|
S UedaS YamagishiT MatsuiAdministration of
pigment epithelium-derived factor inhibits left ventricular
remodeling and improves cardiac function in rats with acute
myocardial infarctionAm J
Pathol2591598201110.1016/j.ajpath.2010.10.01821281791
|
|
5.
|
MK MisraM SarwatP BhakuniOxidative stress
and ischemic myocardial syndromesMed Sci
Monit15RA209RA219200919789524
|
|
6.
|
H ZhangWR WangR LinBuyang Huanwu decoction
ameliorates coronary heart disease with Qi deficiency and blood
stasis syndrome by reducing CRP and CD40 in ratsJ
Ethnopharmacol13098102201010.1016/j.jep.2010.04.01720420893
|
|
7.
|
HQ YinB WangJD ZhangEffect of traditional
Chinese medicine Shu-Mai-Tang on attenuating TNFα-induced
myocardial fibrosis in myocardial ischemia ratsJ
Ethnopharmacol1881331392008
|
|
8.
|
Y LiuR LinXL ShiThe roles of buyang huanwu
decoction in anti-inflammation, antioxidation and regulation of
lipid metabolism in rats with myocardial ischemiaEvid Based
Complement Alternat MedMarch102011(E-pub ahead of print).
|
|
9.
|
CI AsliF RochelleW LorenHerbal and
traditional Chinese medicine for the treatment of cardiovascular
complications in diabetes mellitusCurr Diabetes
Rev4320328200810.2174/15733990878624114218991600
|
|
10.
|
C Ibarra-AlvaradoA RojasS
MendozaVasoactive and antioxidant activities of plants used in
Mexican traditional medicine for the treatment of cardiovascular
diseasesPharm Biol7732739201010.3109/1388020090327128020645769
|
|
11.
|
SU ChonBG HeoYS ParkTotal phenolics level,
antioxidant activities and cytotoxicity of young sprouts of some
traditional Korean salad plantsPlant Foods Hum
Nutr12531200910.1007/s11130-008-0092-x19016328
|
|
12.
|
HQ HuangDan-Shen-Yin and Er-Chen-Tang
treat diabetic gastroparesis 40 casesJ New Chinese Med39682007
|
|
13.
|
MF HuJian-Pi-Wan and Dan-Shen-Yin treat
diabetic gastroparesis 60 casesChin J Tradit Med Sci
Tech161501512009
|
|
14.
|
M XieSheng-Mai-San and Dan-Shen-Yin treat
coronary heart disease 60 casesChin Med Mod Dist Educ
Chin613572008
|
|
15.
|
RS LiuJia-Wei-Dan-Shen-Yin treat coronary
heart disease 68 casesChin J Integr Med on Cardio-/Cerebrovascular
Disease86042010
|
|
16.
|
D PinkelThe use of body surface area as a
criterion of drug dosage in cancer chemotherapyCancer
Res18853856195813573353
|
|
17.
|
F QinYX LiuHW ZhaoChinese medicinal
formula Guan-Xin-Er-Hao protects the heart against oxidative stress
induced by acute ischemic myocardial injury in
ratsPhytomedicine16215221200910.1016/j.phymed.2008.08.00518951001
|
|
18.
|
HW ZhaoF QinYX LiuAntiapoptotic mechanisms
of Chinese medicine formula, Guan-Xin-Er-Hao, in the rat ischemic
heartTohoku J Exp Med216309316200810.1620/tjem.216.30919060445
|
|
19.
|
J ZhaoX HuangW TangEffect of oriental
herbal prescription Guan-Xin-Er-Hao on coronary flow in healthy
volunteers and anti-apoptosis on myocardial ischemia-reperfusion in
rat modelsPhytother Res21926931200710.1002/ptr.219417582591
|
|
20.
|
H ThieleL HildebrandC SchirdewahnImpact of
high-dose N-Acetylcysteine versus placebo on contrast-induced
nephropathy and myocardial reperfusion injury in unselected
patients with ST-segment elevation myocardial infarction undergoing
primary percutaneous coronary intervention. The LIPSIA-N-ACC
(Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig
Immediate PercutaneouS Coronary Intervention Acute Myocardial
Infarction N-ACC)Trial J Am Coll Cardiol55220122092010
|
|
21.
|
HY LingYJ LouTotal flavones from
Elsholtzia blanda reduce infarct size during acute
myocardial ischemia by inhibiting myocardial apoptosis in ratsJ
Ethnopharmacol1011691752005
|
|
22.
|
JY ZhouY FanJL KongDZ WuZB HuEffect of
components isolated from Astragalus membranaceus Bunge on
cardiac function injured by myocardial ischemia reperfusion in
ratsZhongguo Zhong Yao Za Zhi253003022000
|
|
23.
|
BL QiB ChengEffect of the daidzein on
protect of cardiovascular in unsexed ratsJ Chin Clin
Med318192002
|
|
24.
|
A AgrawalCRP after 2004Mol
Immunol42927930200510.1016/j.molimm.2004.09.028
|
|
25.
|
GK HanssonP LibbyThe immune response in
atherosclerosis: a double-edged swordNat Rev
Immunol6508519200610.1038/nri188216778830
|
|
26.
|
P LibbyJT WillersonE BraunwaldC-reactive
protein and coronary heart diseaseN Engl J
Med351295298200410.1056/NEJM20040715351031815257564
|
|
27.
|
MB PepysGM HirschfieldC-reactive protein:
a critical updateJ Clin
Invest11118051812200310.1172/JCI20031892112813013
|
|
28.
|
DI BuckleyRW FuM FreemanC-reactive protein
as a risk factor for coronary heart disease: a systematic review
and meta-analyses for the U.S. preventive services task forceAnn
Intern
Med151483495200910.7326/0003-4819-151-7-200910060-0000919805771
|
|
29.
|
S KojimaT FunahashiT SakamotoThe variation
of plasma concentrations of a novel, adipocyte derived protein,
adiponectin, in patients with acute myocardial
infarctionHeart89667668200310.1136/heart.89.6.66712748233
|
|
30.
|
F BeerAK SoutarML BaltzLow density and
very low density lipoproteins are selectively bound by aggregated
C-reactive proteinJ Exp
Med156230242198210.1084/jem.156.1.2307086355
|
|
31.
|
MB PepysIF RoweML BaltzC-reactive protein:
binding to lipids and lipoproteinsInt Rev Exp
Pathol278311119853915746
|
|
32.
|
YX ZhangWJ CliffGI SchoeflCoronary
C-reactive protein distribution: its relation to development of
atherosclerosisAtherosclerosis145375379199910.1016/S0021-9150(99)00105-710488966
|
|
33.
|
N RifaiPM RidkerHigh-sensitivity
C-reactive protein: a novel and promising marker of coronary heart
diseaseClin Chem47403411200111238289
|
|
34.
|
AK AbbasAH LichtmanJS PoberCellular and
Molecular ImmunologyWB SaundersPhiladelphia2262421991
|
|
35.
|
P KrishnamurthyE LambersS VermaMyocardial
knockdown of mRNA-stabilizing protein HuR attenuates post-MI
inflammatory response and left ventricular dysfunction in
IL-10-null miceFASEB
J2424842494201010.1096/fj.09-14981520219984
|
|
36.
|
KA KrownMT PageC NguyenTumor necrosis
factor alpha-induced apoptosis in cardiac myocytes: involvement of
the sphingolipid signaling cascade in cardiac cell deathJ Clin
Invest9828542865199610.1172/JCI119114
|
|
37.
|
CD FilippoS CuzzocreaF RossiOxidative
stress as the leading cause of acute myocardial infarction in
diabeticsCardiovasc Drug
Rev247787200610.1111/j.1527-3466.2006.00077.x16961722
|
|
38.
|
ME DavisG SeshadriS DikalovDelivery of SOD
with polyketal particles protects rats from acute myocardial
infarctionCirculation120S7472009
|
|
39.
|
W ZhengLZ HuangL ZhaoSuperoxide dismutase
activity and malondialdehyde level in plasma and morphological
evaluation of acute severe hemorrhagic shock in ratsAm J Emerg
Med265458200810.1016/j.ajem.2007.02.00718082781
|
|
40.
|
H Gersterβ-Carotene, vitamin E and vitamin
C in different stages of experimental carcinogenesisEur J Clin
Nutr491551681995
|
|
41.
|
D KonukogluO SerinDG KemerliA study on the
carotid artery intima-media thickness and its association with
lipid peroxidationClin Chim
Acta2779198199810.1016/S0009-8981(98)00117-X9776048
|
